"The Risk For Bristol"
doi:10.1016/j.cmet.2012.12.011 26
Until then, the notification said GLP-1 RAs should only be prescribed for their licensed indication, and clinicians should avoid initiating people with T2DM on GLP-1 RAs for the duration of the national shortage
Evidence: A clinical study presented at the European Society for Paediatric Endocrinology (2024) found that combining Metformin with a GLP-1 analog improved weight outcomes compared to either drug alone Safety: The MetforminGLP-1 combination for weight loss is generally well-tolerated
Phentermine/topiramate is a combination medication sold by Vivus under the brand name Qsymia
In addition, GPX4 inhibitors remain challenging to use in vivo owing to their poor bioavailability, and pharmacological inhibition of GPX4 carries a substantial risk of systemic toxicity, as demonstrated in GPX4 knockout mouse models 25,26,27 Thus, modulating the CoQ 10 redox cycle, either by inhibiting ubiquinol (CoQ 10 H 2 , reduced) formation or altering oxidoreductase activity, has emerged as an alternative therapeutic strategy for ferroptosis-based cancer therapy